nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—CYP2A6—Bupropion—obesity	0.0944	0.163	CbGbCtD
Dapagliflozin—CYP1A2—Phentermine—obesity	0.0424	0.0731	CbGbCtD
Dapagliflozin—CYP1A2—Phenylpropanolamine—obesity	0.0404	0.0697	CbGbCtD
Dapagliflozin—CYP2C9—Phentermine—obesity	0.0382	0.0658	CbGbCtD
Dapagliflozin—CYP1A2—Bupropion—obesity	0.036	0.0621	CbGbCtD
Dapagliflozin—CYP2D6—Phentermine—obesity	0.0349	0.0602	CbGbCtD
Dapagliflozin—CYP2C9—Bupropion—obesity	0.0325	0.056	CbGbCtD
Dapagliflozin—CYP2D6—Bupropion—obesity	0.0297	0.0512	CbGbCtD
Dapagliflozin—CYP3A4—Sibutramine—obesity	0.0293	0.0505	CbGbCtD
Dapagliflozin—CYP2D6—Methamphetamine—obesity	0.0279	0.0481	CbGbCtD
Dapagliflozin—CYP1A2—Cimetidine—obesity	0.0264	0.0456	CbGbCtD
Dapagliflozin—CYP2C9—Cimetidine—obesity	0.0238	0.0411	CbGbCtD
Dapagliflozin—ABCB1—Cimetidine—obesity	0.0231	0.0399	CbGbCtD
Dapagliflozin—CYP3A4—Benzphetamine—obesity	0.0222	0.0383	CbGbCtD
Dapagliflozin—CYP2D6—Cimetidine—obesity	0.0218	0.0376	CbGbCtD
Dapagliflozin—CYP3A4—Bupropion—obesity	0.0189	0.0325	CbGbCtD
Dapagliflozin—CYP3A4—Orlistat—obesity	0.0154	0.0265	CbGbCtD
Dapagliflozin—CYP3A4—Cimetidine—obesity	0.0139	0.0239	CbGbCtD
Dapagliflozin—Vaginitis bacterial—Bupropion—obesity	0.0129	0.0835	CcSEcCtD
Dapagliflozin—CYP3A4—Topiramate—obesity	0.00907	0.0156	CbGbCtD
Dapagliflozin—SLC5A4—digestive system—obesity	0.00412	0.0865	CbGeAlD
Dapagliflozin—SLC5A11—pituitary gland—obesity	0.00399	0.0838	CbGeAlD
Dapagliflozin—SLC5A1—respiratory system—obesity	0.00372	0.0781	CbGeAlD
Dapagliflozin—SLC5A1—cardiovascular system—obesity	0.00285	0.0598	CbGeAlD
Dapagliflozin—Genital candidiasis—Topiramate—obesity	0.00271	0.0175	CcSEcCtD
Dapagliflozin—UGT2B4—cardiovascular system—obesity	0.00263	0.0551	CbGeAlD
Dapagliflozin—SLC5A2—endocrine gland—obesity	0.00258	0.0542	CbGeAlD
Dapagliflozin—SLC5A1—pituitary gland—obesity	0.00252	0.053	CbGeAlD
Dapagliflozin—SLC5A1—digestive system—obesity	0.00237	0.0497	CbGeAlD
Dapagliflozin—Urine output increased—Diethylpropion—obesity	0.00189	0.0123	CcSEcCtD
Dapagliflozin—Fracture—Orlistat—obesity	0.00189	0.0123	CcSEcCtD
Dapagliflozin—Multiple fractures—Orlistat—obesity	0.00189	0.0123	CcSEcCtD
Dapagliflozin—UGT2B4—endocrine gland—obesity	0.0018	0.0378	CbGeAlD
Dapagliflozin—Cerebrovascular accident—Phentermine—obesity	0.00178	0.0116	CcSEcCtD
Dapagliflozin—Polyuria—Diethylpropion—obesity	0.00173	0.0112	CcSEcCtD
Dapagliflozin—Dysuria—Phendimetrazine—obesity	0.00173	0.0112	CcSEcCtD
Dapagliflozin—Pollakiuria—Phendimetrazine—obesity	0.00171	0.0111	CcSEcCtD
Dapagliflozin—Vulvovaginal mycotic infection—Bupropion—obesity	0.0017	0.011	CcSEcCtD
Dapagliflozin—UGT2B4—liver—obesity	0.00162	0.0341	CbGeAlD
Dapagliflozin—Cerebrovascular accident—Diethylpropion—obesity	0.00155	0.0101	CcSEcCtD
Dapagliflozin—Lung disorder—Sibutramine—obesity	0.0015	0.00975	CcSEcCtD
Dapagliflozin—UGT1A9—digestive system—obesity	0.00149	0.0313	CbGeAlD
Dapagliflozin—Angina pectoris—Phentermine—obesity	0.00147	0.00953	CcSEcCtD
Dapagliflozin—Blood creatinine increased—Cimetidine—obesity	0.00135	0.00878	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Phentermine—obesity	0.00133	0.0086	CcSEcCtD
Dapagliflozin—Myocardial infarction—Phentermine—obesity	0.00132	0.00855	CcSEcCtD
Dapagliflozin—Neoplasm malignant—Sibutramine—obesity	0.00125	0.00808	CcSEcCtD
Dapagliflozin—UGT1A9—endocrine gland—obesity	0.00123	0.0258	CbGeAlD
Dapagliflozin—Dysuria—Diethylpropion—obesity	0.00123	0.00796	CcSEcCtD
Dapagliflozin—Fungal infection—Bupropion—obesity	0.0012	0.00779	CcSEcCtD
Dapagliflozin—UGT2B7—digestive system—obesity	0.0012	0.0252	CbGeAlD
Dapagliflozin—Hyperhidrosis—Benzphetamine—obesity	0.00111	0.00722	CcSEcCtD
Dapagliflozin—UGT1A9—liver—obesity	0.00111	0.0233	CbGeAlD
Dapagliflozin—Renal failure—Cimetidine—obesity	0.00109	0.0071	CcSEcCtD
Dapagliflozin—Vaginal infection—Orlistat—obesity	0.00104	0.00673	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Methamphetamine—obesity	0.00103	0.00669	CcSEcCtD
Dapagliflozin—Canagliflozin—ALB—obesity	0.00103	1	CrCbGaD
Dapagliflozin—Constipation—Methamphetamine—obesity	0.00102	0.00662	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Phendimetrazine—obesity	0.00101	0.00658	CcSEcCtD
Dapagliflozin—Blood urea increased—Sibutramine—obesity	0.001	0.00651	CcSEcCtD
Dapagliflozin—Nocturia—Bupropion—obesity	0.001	0.00648	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Benzphetamine—obesity	0.000994	0.00645	CcSEcCtD
Dapagliflozin—Neoplasm—Orlistat—obesity	0.000994	0.00644	CcSEcCtD
Dapagliflozin—Urine output increased—Orlistat—obesity	0.000994	0.00644	CcSEcCtD
Dapagliflozin—UGT2B7—endocrine gland—obesity	0.000992	0.0208	CbGeAlD
Dapagliflozin—Neoplasm—Sibutramine—obesity	0.000962	0.00624	CcSEcCtD
Dapagliflozin—Urticaria—Methamphetamine—obesity	0.000949	0.00615	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Orlistat—obesity	0.000917	0.00595	CcSEcCtD
Dapagliflozin—Urticaria—Benzphetamine—obesity	0.000915	0.00593	CcSEcCtD
Dapagliflozin—CYP2A6—adipose tissue—obesity	0.000914	0.0192	CbGeAlD
Dapagliflozin—Polyuria—Orlistat—obesity	0.000909	0.00589	CcSEcCtD
Dapagliflozin—Hypertension—Phentermine—obesity	0.000908	0.00589	CcSEcCtD
Dapagliflozin—Constipation—Phendimetrazine—obesity	0.000898	0.00582	CcSEcCtD
Dapagliflozin—Phlebitis—Sibutramine—obesity	0.000896	0.00581	CcSEcCtD
Dapagliflozin—UGT2B7—liver—obesity	0.000894	0.0188	CbGeAlD
Dapagliflozin—Diabetes mellitus—Sibutramine—obesity	0.000888	0.00576	CcSEcCtD
Dapagliflozin—Hypersensitivity—Methamphetamine—obesity	0.00088	0.00571	CcSEcCtD
Dapagliflozin—Vaginal infection—Bupropion—obesity	0.000876	0.00568	CcSEcCtD
Dapagliflozin—Oedema—Phentermine—obesity	0.000858	0.00556	CcSEcCtD
Dapagliflozin—Hypersensitivity—Benzphetamine—obesity	0.000849	0.0055	CcSEcCtD
Dapagliflozin—Neoplasm—Bupropion—obesity	0.000838	0.00544	CcSEcCtD
Dapagliflozin—Urine output increased—Bupropion—obesity	0.000838	0.00544	CcSEcCtD
Dapagliflozin—Thirst—Orlistat—obesity	0.000838	0.00544	CcSEcCtD
Dapagliflozin—Hypotension—Phenylpropanolamine—obesity	0.000838	0.00543	CcSEcCtD
Dapagliflozin—CYP2D6—hindbrain—obesity	0.000829	0.0174	CbGeAlD
Dapagliflozin—Hypoglycaemia—Orlistat—obesity	0.000818	0.0053	CcSEcCtD
Dapagliflozin—Thirst—Sibutramine—obesity	0.000811	0.00526	CcSEcCtD
Dapagliflozin—Hypoglycaemia—Sibutramine—obesity	0.000791	0.00513	CcSEcCtD
Dapagliflozin—Dizziness—Methamphetamine—obesity	0.00079	0.00512	CcSEcCtD
Dapagliflozin—Cerebrovascular accident—Sibutramine—obesity	0.000788	0.00511	CcSEcCtD
Dapagliflozin—Phlebitis—Bupropion—obesity	0.000781	0.00507	CcSEcCtD
Dapagliflozin—Pain in extremity—Sibutramine—obesity	0.000772	0.00501	CcSEcCtD
Dapagliflozin—Discomfort—Diethylpropion—obesity	0.000769	0.00499	CcSEcCtD
Dapagliflozin—Constipation—Phenylpropanolamine—obesity	0.000767	0.00497	CcSEcCtD
Dapagliflozin—Polyuria—Bupropion—obesity	0.000767	0.00497	CcSEcCtD
Dapagliflozin—Dizziness—Benzphetamine—obesity	0.000762	0.00494	CcSEcCtD
Dapagliflozin—Headache—Methamphetamine—obesity	0.000748	0.00485	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Phentermine—obesity	0.000741	0.0048	CcSEcCtD
Dapagliflozin—Constipation—Phentermine—obesity	0.000734	0.00476	CcSEcCtD
Dapagliflozin—Blood creatinine increased—Sibutramine—obesity	0.000723	0.00469	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Diethylpropion—obesity	0.000722	0.00468	CcSEcCtD
Dapagliflozin—Headache—Benzphetamine—obesity	0.000722	0.00468	CcSEcCtD
Dapagliflozin—Dehydration—Sibutramine—obesity	0.000718	0.00466	CcSEcCtD
Dapagliflozin—CYP1A2—respiratory system—obesity	0.000711	0.0149	CbGeAlD
Dapagliflozin—Anaphylactic shock—Cimetidine—obesity	0.00071	0.00461	CcSEcCtD
Dapagliflozin—Thirst—Bupropion—obesity	0.000707	0.00459	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Sibutramine—obesity	0.000705	0.00457	CcSEcCtD
Dapagliflozin—CYP1A1—respiratory system—obesity	0.000701	0.0147	CbGeAlD
Dapagliflozin—Dizziness—Phendimetrazine—obesity	0.000694	0.0045	CcSEcCtD
Dapagliflozin—Hypoglycaemia—Bupropion—obesity	0.00069	0.00447	CcSEcCtD
Dapagliflozin—Influenza—Orlistat—obesity	0.00069	0.00447	CcSEcCtD
Dapagliflozin—Cerebrovascular accident—Bupropion—obesity	0.000687	0.00445	CcSEcCtD
Dapagliflozin—Nausea—Benzphetamine—obesity	0.000684	0.00444	CcSEcCtD
Dapagliflozin—Urticaria—Phentermine—obesity	0.000682	0.00442	CcSEcCtD
Dapagliflozin—Pain in extremity—Bupropion—obesity	0.000673	0.00437	CcSEcCtD
Dapagliflozin—Influenza—Sibutramine—obesity	0.000667	0.00433	CcSEcCtD
Dapagliflozin—Hypersensitivity—Phenylpropanolamine—obesity	0.000661	0.00428	CcSEcCtD
Dapagliflozin—Headache—Phendimetrazine—obesity	0.000658	0.00426	CcSEcCtD
Dapagliflozin—Angina pectoris—Sibutramine—obesity	0.00065	0.00422	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Diethylpropion—obesity	0.000645	0.00418	CcSEcCtD
Dapagliflozin—CYP2A6—liver—obesity	0.000641	0.0135	CbGeAlD
Dapagliflozin—Constipation—Diethylpropion—obesity	0.000638	0.00414	CcSEcCtD
Dapagliflozin—Nocturia—Topiramate—obesity	0.000637	0.00413	CcSEcCtD
Dapagliflozin—Dehydration—Bupropion—obesity	0.000626	0.00406	CcSEcCtD
Dapagliflozin—Dysuria—Sibutramine—obesity	0.000624	0.00405	CcSEcCtD
Dapagliflozin—Nausea—Phendimetrazine—obesity	0.000624	0.00404	CcSEcCtD
Dapagliflozin—Pollakiuria—Sibutramine—obesity	0.000617	0.004	CcSEcCtD
Dapagliflozin—Infestation NOS—Orlistat—obesity	0.000615	0.00399	CcSEcCtD
Dapagliflozin—Infestation—Orlistat—obesity	0.000615	0.00399	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Bupropion—obesity	0.000615	0.00399	CcSEcCtD
Dapagliflozin—Constipation—Cimetidine—obesity	0.000607	0.00394	CcSEcCtD
Dapagliflozin—Renal failure—Orlistat—obesity	0.000604	0.00392	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Bupropion—obesity	0.000602	0.0039	CcSEcCtD
Dapagliflozin—Urinary tract infection—Orlistat—obesity	0.000598	0.00388	CcSEcCtD
Dapagliflozin—Urticaria—Diethylpropion—obesity	0.000593	0.00385	CcSEcCtD
Dapagliflozin—Dizziness—Phenylpropanolamine—obesity	0.000593	0.00385	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Sibutramine—obesity	0.000587	0.0038	CcSEcCtD
Dapagliflozin—Renal failure—Sibutramine—obesity	0.000585	0.00379	CcSEcCtD
Dapagliflozin—Myocardial infarction—Sibutramine—obesity	0.000583	0.00378	CcSEcCtD
Dapagliflozin—Influenza—Bupropion—obesity	0.000582	0.00377	CcSEcCtD
Dapagliflozin—Urinary tract infection—Sibutramine—obesity	0.000578	0.00375	CcSEcCtD
Dapagliflozin—Dizziness—Phentermine—obesity	0.000567	0.00368	CcSEcCtD
Dapagliflozin—Rash—Phenylpropanolamine—obesity	0.000565	0.00367	CcSEcCtD
Dapagliflozin—Dermatitis—Phenylpropanolamine—obesity	0.000565	0.00366	CcSEcCtD
Dapagliflozin—Body temperature increased—Cimetidine—obesity	0.000562	0.00364	CcSEcCtD
Dapagliflozin—Vaginal infection—Topiramate—obesity	0.000558	0.00362	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Orlistat—obesity	0.000545	0.00353	CcSEcCtD
Dapagliflozin—Dysuria—Bupropion—obesity	0.000544	0.00353	CcSEcCtD
Dapagliflozin—Urethral disorder—Orlistat—obesity	0.000541	0.00351	CcSEcCtD
Dapagliflozin—Rash—Phentermine—obesity	0.000541	0.00351	CcSEcCtD
Dapagliflozin—Dermatitis—Phentermine—obesity	0.000541	0.00351	CcSEcCtD
Dapagliflozin—Headache—Phentermine—obesity	0.000538	0.00349	CcSEcCtD
Dapagliflozin—Pollakiuria—Bupropion—obesity	0.000537	0.00349	CcSEcCtD
Dapagliflozin—Neoplasm—Topiramate—obesity	0.000534	0.00346	CcSEcCtD
Dapagliflozin—Urine output increased—Topiramate—obesity	0.000534	0.00346	CcSEcCtD
Dapagliflozin—Nausea—Phenylpropanolamine—obesity	0.000533	0.00345	CcSEcCtD
Dapagliflozin—Hypersensitivity—Cimetidine—obesity	0.000523	0.00339	CcSEcCtD
Dapagliflozin—Infestation NOS—Bupropion—obesity	0.000519	0.00336	CcSEcCtD
Dapagliflozin—Infestation—Bupropion—obesity	0.000519	0.00336	CcSEcCtD
Dapagliflozin—CYP2C9—cardiovascular system—obesity	0.000517	0.0109	CbGeAlD
Dapagliflozin—Acute coronary syndrome—Bupropion—obesity	0.000511	0.00332	CcSEcCtD
Dapagliflozin—Nausea—Phentermine—obesity	0.00051	0.00331	CcSEcCtD
Dapagliflozin—Myocardial infarction—Bupropion—obesity	0.000509	0.0033	CcSEcCtD
Dapagliflozin—Urinary tract infection—Bupropion—obesity	0.000504	0.00327	CcSEcCtD
Dapagliflozin—Phlebitis—Topiramate—obesity	0.000498	0.00323	CcSEcCtD
Dapagliflozin—Dizziness—Diethylpropion—obesity	0.000494	0.0032	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Topiramate—obesity	0.000493	0.0032	CcSEcCtD
Dapagliflozin—Polyuria—Topiramate—obesity	0.000488	0.00317	CcSEcCtD
Dapagliflozin—Malnutrition—Orlistat—obesity	0.000481	0.00312	CcSEcCtD
Dapagliflozin—CYP1A1—adipose tissue—obesity	0.000474	0.00994	CbGeAlD
Dapagliflozin—Rash—Diethylpropion—obesity	0.000471	0.00305	CcSEcCtD
Dapagliflozin—Dermatitis—Diethylpropion—obesity	0.00047	0.00305	CcSEcCtD
Dapagliflozin—Dizziness—Cimetidine—obesity	0.00047	0.00305	CcSEcCtD
Dapagliflozin—Headache—Diethylpropion—obesity	0.000468	0.00303	CcSEcCtD
Dapagliflozin—Malnutrition—Sibutramine—obesity	0.000465	0.00302	CcSEcCtD
Dapagliflozin—Back pain—Orlistat—obesity	0.000465	0.00301	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Bupropion—obesity	0.00046	0.00298	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Bupropion—obesity	0.000458	0.00297	CcSEcCtD
Dapagliflozin—Urethral disorder—Bupropion—obesity	0.000457	0.00296	CcSEcCtD
Dapagliflozin—CYP1A2—digestive system—obesity	0.000452	0.00949	CbGeAlD
Dapagliflozin—Thirst—Topiramate—obesity	0.000451	0.00292	CcSEcCtD
Dapagliflozin—Back pain—Sibutramine—obesity	0.00045	0.00292	CcSEcCtD
Dapagliflozin—Rash—Cimetidine—obesity	0.000448	0.0029	CcSEcCtD
Dapagliflozin—Dermatitis—Cimetidine—obesity	0.000447	0.0029	CcSEcCtD
Dapagliflozin—CYP1A1—digestive system—obesity	0.000446	0.00936	CbGeAlD
Dapagliflozin—Headache—Cimetidine—obesity	0.000445	0.00289	CcSEcCtD
Dapagliflozin—Nausea—Diethylpropion—obesity	0.000443	0.00288	CcSEcCtD
Dapagliflozin—Hypoglycaemia—Topiramate—obesity	0.000439	0.00285	CcSEcCtD
Dapagliflozin—Angioedema—Orlistat—obesity	0.000439	0.00285	CcSEcCtD
Dapagliflozin—Hyponatraemia—Topiramate—obesity	0.000431	0.00279	CcSEcCtD
Dapagliflozin—CYP2C9—digestive system—obesity	0.000429	0.00901	CbGeAlD
Dapagliflozin—Pain in extremity—Topiramate—obesity	0.000429	0.00278	CcSEcCtD
Dapagliflozin—Angioedema—Sibutramine—obesity	0.000425	0.00276	CcSEcCtD
Dapagliflozin—Nausea—Cimetidine—obesity	0.000422	0.00274	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000406	0.00263	CcSEcCtD
Dapagliflozin—Malnutrition—Bupropion—obesity	0.000405	0.00263	CcSEcCtD
Dapagliflozin—Discomfort—Orlistat—obesity	0.000404	0.00262	CcSEcCtD
Dapagliflozin—Blood creatinine increased—Topiramate—obesity	0.000402	0.00261	CcSEcCtD
Dapagliflozin—Hypertension—Sibutramine—obesity	0.000401	0.0026	CcSEcCtD
Dapagliflozin—Dehydration—Topiramate—obesity	0.000399	0.00259	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Orlistat—obesity	0.000392	0.00254	CcSEcCtD
Dapagliflozin—Oedema—Orlistat—obesity	0.000392	0.00254	CcSEcCtD
Dapagliflozin—Back pain—Bupropion—obesity	0.000392	0.00254	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Topiramate—obesity	0.000392	0.00254	CcSEcCtD
Dapagliflozin—Discomfort—Sibutramine—obesity	0.000391	0.00254	CcSEcCtD
Dapagliflozin—Infection—Orlistat—obesity	0.00039	0.00253	CcSEcCtD
Dapagliflozin—ABCB1—islet of Langerhans—obesity	0.000386	0.0081	CbGeAlD
Dapagliflozin—Nasopharyngitis—Topiramate—obesity	0.000384	0.00249	CcSEcCtD
Dapagliflozin—Skin disorder—Orlistat—obesity	0.000381	0.00247	CcSEcCtD
Dapagliflozin—Oedema—Sibutramine—obesity	0.00038	0.00246	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Sibutramine—obesity	0.00038	0.00246	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Orlistat—obesity	0.000379	0.00246	CcSEcCtD
Dapagliflozin—Infection—Sibutramine—obesity	0.000377	0.00244	CcSEcCtD
Dapagliflozin—CYP1A2—endocrine gland—obesity	0.000373	0.00784	CbGeAlD
Dapagliflozin—Angioedema—Bupropion—obesity	0.00037	0.0024	CcSEcCtD
Dapagliflozin—Skin disorder—Sibutramine—obesity	0.000369	0.00239	CcSEcCtD
Dapagliflozin—CYP1A1—endocrine gland—obesity	0.000368	0.00773	CbGeAlD
Dapagliflozin—Hyperhidrosis—Sibutramine—obesity	0.000367	0.00238	CcSEcCtD
Dapagliflozin—ABCB1—respiratory system—obesity	0.000364	0.00765	CbGeAlD
Dapagliflozin—Angina pectoris—Topiramate—obesity	0.000361	0.00234	CcSEcCtD
Dapagliflozin—Hypotension—Sibutramine—obesity	0.000355	0.0023	CcSEcCtD
Dapagliflozin—CYP2C9—endocrine gland—obesity	0.000354	0.00744	CbGeAlD
Dapagliflozin—Hypertension—Bupropion—obesity	0.00035	0.00227	CcSEcCtD
Dapagliflozin—Dysuria—Topiramate—obesity	0.000347	0.00225	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000343	0.00222	CcSEcCtD
Dapagliflozin—Pollakiuria—Topiramate—obesity	0.000342	0.00222	CcSEcCtD
Dapagliflozin—Discomfort—Bupropion—obesity	0.000341	0.00221	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Orlistat—obesity	0.000339	0.0022	CcSEcCtD
Dapagliflozin—CYP1A2—liver—obesity	0.000337	0.00707	CbGeAlD
Dapagliflozin—CYP1A1—liver—obesity	0.000332	0.00697	CbGeAlD
Dapagliflozin—Oedema—Bupropion—obesity	0.000331	0.00215	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Bupropion—obesity	0.000331	0.00215	CcSEcCtD
Dapagliflozin—Infestation—Topiramate—obesity	0.000331	0.00214	CcSEcCtD
Dapagliflozin—Infestation NOS—Topiramate—obesity	0.000331	0.00214	CcSEcCtD
Dapagliflozin—Infection—Bupropion—obesity	0.000329	0.00213	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Sibutramine—obesity	0.000328	0.00212	CcSEcCtD
Dapagliflozin—CYP3A4—digestive system—obesity	0.000327	0.00687	CbGeAlD
Dapagliflozin—Renal failure—Topiramate—obesity	0.000325	0.00211	CcSEcCtD
Dapagliflozin—Constipation—Sibutramine—obesity	0.000325	0.0021	CcSEcCtD
Dapagliflozin—CYP2D6—digestive system—obesity	0.000322	0.00676	CbGeAlD
Dapagliflozin—Skin disorder—Bupropion—obesity	0.000321	0.00208	CcSEcCtD
Dapagliflozin—Urinary tract infection—Topiramate—obesity	0.000321	0.00208	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Bupropion—obesity	0.00032	0.00207	CcSEcCtD
Dapagliflozin—CYP2C9—liver—obesity	0.00032	0.00671	CbGeAlD
Dapagliflozin—Urticaria—Orlistat—obesity	0.000312	0.00202	CcSEcCtD
Dapagliflozin—Body temperature increased—Orlistat—obesity	0.00031	0.00201	CcSEcCtD
Dapagliflozin—Hypotension—Bupropion—obesity	0.000309	0.002	CcSEcCtD
Dapagliflozin—ABCB1—adrenal cortex—obesity	0.000306	0.00642	CbGeAlD
Dapagliflozin—Urticaria—Sibutramine—obesity	0.000302	0.00196	CcSEcCtD
Dapagliflozin—Body temperature increased—Sibutramine—obesity	0.0003	0.00195	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Topiramate—obesity	0.000293	0.0019	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Topiramate—obesity	0.000292	0.00189	CcSEcCtD
Dapagliflozin—Urethral disorder—Topiramate—obesity	0.000291	0.00189	CcSEcCtD
Dapagliflozin—Hypersensitivity—Orlistat—obesity	0.000289	0.00187	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Bupropion—obesity	0.000286	0.00185	CcSEcCtD
Dapagliflozin—Constipation—Bupropion—obesity	0.000283	0.00183	CcSEcCtD
Dapagliflozin—Hypersensitivity—Sibutramine—obesity	0.00028	0.00181	CcSEcCtD
Dapagliflozin—ABCB1—cardiovascular system—obesity	0.000279	0.00586	CbGeAlD
Dapagliflozin—CYP3A4—endocrine gland—obesity	0.00027	0.00568	CbGeAlD
Dapagliflozin—CYP2D6—endocrine gland—obesity	0.000266	0.00558	CbGeAlD
Dapagliflozin—Urticaria—Bupropion—obesity	0.000263	0.0017	CcSEcCtD
Dapagliflozin—Body temperature increased—Bupropion—obesity	0.000262	0.0017	CcSEcCtD
Dapagliflozin—Dizziness—Orlistat—obesity	0.000259	0.00168	CcSEcCtD
Dapagliflozin—Malnutrition—Topiramate—obesity	0.000258	0.00167	CcSEcCtD
Dapagliflozin—Dizziness—Sibutramine—obesity	0.000251	0.00163	CcSEcCtD
Dapagliflozin—Back pain—Topiramate—obesity	0.00025	0.00162	CcSEcCtD
Dapagliflozin—Rash—Orlistat—obesity	0.000247	0.0016	CcSEcCtD
Dapagliflozin—Dermatitis—Orlistat—obesity	0.000247	0.0016	CcSEcCtD
Dapagliflozin—ABCB1—pituitary gland—obesity	0.000247	0.00519	CbGeAlD
Dapagliflozin—ABCB1—adipose tissue—obesity	0.000246	0.00516	CbGeAlD
Dapagliflozin—Headache—Orlistat—obesity	0.000246	0.00159	CcSEcCtD
Dapagliflozin—Hypersensitivity—Bupropion—obesity	0.000244	0.00158	CcSEcCtD
Dapagliflozin—CYP3A4—liver—obesity	0.000244	0.00512	CbGeAlD
Dapagliflozin—CYP2D6—liver—obesity	0.00024	0.00504	CbGeAlD
Dapagliflozin—Rash—Sibutramine—obesity	0.000239	0.00155	CcSEcCtD
Dapagliflozin—Dermatitis—Sibutramine—obesity	0.000239	0.00155	CcSEcCtD
Dapagliflozin—Headache—Sibutramine—obesity	0.000238	0.00154	CcSEcCtD
Dapagliflozin—Nausea—Orlistat—obesity	0.000233	0.00151	CcSEcCtD
Dapagliflozin—ABCB1—digestive system—obesity	0.000232	0.00486	CbGeAlD
Dapagliflozin—Nausea—Sibutramine—obesity	0.000225	0.00146	CcSEcCtD
Dapagliflozin—Hypertension—Topiramate—obesity	0.000223	0.00145	CcSEcCtD
Dapagliflozin—ABCB1—adrenal gland—obesity	0.000221	0.00463	CbGeAlD
Dapagliflozin—Dizziness—Bupropion—obesity	0.000219	0.00142	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000218	0.00142	CcSEcCtD
Dapagliflozin—Discomfort—Topiramate—obesity	0.000217	0.00141	CcSEcCtD
Dapagliflozin—Oedema—Topiramate—obesity	0.000211	0.00137	CcSEcCtD
Dapagliflozin—Infection—Topiramate—obesity	0.000209	0.00136	CcSEcCtD
Dapagliflozin—Rash—Bupropion—obesity	0.000209	0.00135	CcSEcCtD
Dapagliflozin—Dermatitis—Bupropion—obesity	0.000208	0.00135	CcSEcCtD
Dapagliflozin—Headache—Bupropion—obesity	0.000207	0.00134	CcSEcCtD
Dapagliflozin—Skin disorder—Topiramate—obesity	0.000205	0.00133	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Topiramate—obesity	0.000204	0.00132	CcSEcCtD
Dapagliflozin—Hypotension—Topiramate—obesity	0.000197	0.00128	CcSEcCtD
Dapagliflozin—Nausea—Bupropion—obesity	0.000197	0.00127	CcSEcCtD
Dapagliflozin—ABCB1—endocrine gland—obesity	0.000191	0.00402	CbGeAlD
Dapagliflozin—Gastrointestinal disorder—Topiramate—obesity	0.000182	0.00118	CcSEcCtD
Dapagliflozin—Constipation—Topiramate—obesity	0.00018	0.00117	CcSEcCtD
Dapagliflozin—ABCB1—liver—obesity	0.000172	0.00362	CbGeAlD
Dapagliflozin—Urticaria—Topiramate—obesity	0.000167	0.00109	CcSEcCtD
Dapagliflozin—Body temperature increased—Topiramate—obesity	0.000167	0.00108	CcSEcCtD
Dapagliflozin—Hypersensitivity—Topiramate—obesity	0.000155	0.00101	CcSEcCtD
Dapagliflozin—Dizziness—Topiramate—obesity	0.000139	0.000904	CcSEcCtD
Dapagliflozin—Rash—Topiramate—obesity	0.000133	0.000862	CcSEcCtD
Dapagliflozin—Dermatitis—Topiramate—obesity	0.000133	0.000861	CcSEcCtD
Dapagliflozin—Headache—Topiramate—obesity	0.000132	0.000856	CcSEcCtD
Dapagliflozin—Nausea—Topiramate—obesity	0.000125	0.000812	CcSEcCtD
Dapagliflozin—CYP3A4—Metabolism—LPIN1—obesity	3.75e-06	1.73e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NQO1—obesity	3.75e-06	1.73e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GOT1—obesity	3.72e-06	1.71e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GGT1—obesity	3.72e-06	1.71e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AKR1C3—obesity	3.7e-06	1.71e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PPARG—obesity	3.7e-06	1.7e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GPX1—obesity	3.68e-06	1.7e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOA5—obesity	3.68e-06	1.69e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	3.67e-06	1.69e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NCOA1—obesity	3.67e-06	1.69e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—POMC—obesity	3.65e-06	1.68e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SCARB1—obesity	3.65e-06	1.68e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	3.63e-06	1.67e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—INS—obesity	3.63e-06	1.67e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SLC2A4—obesity	3.62e-06	1.67e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GCG—obesity	3.62e-06	1.67e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP19A1—obesity	3.61e-06	1.66e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—STK11—obesity	3.61e-06	1.66e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.6e-06	1.66e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SLC2A4—obesity	3.59e-06	1.65e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GCG—obesity	3.59e-06	1.65e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CD36—obesity	3.59e-06	1.65e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYCS—obesity	3.58e-06	1.65e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	3.55e-06	1.63e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYCS—obesity	3.54e-06	1.63e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SREBF1—obesity	3.54e-06	1.63e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GGT1—obesity	3.51e-06	1.62e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GOT1—obesity	3.51e-06	1.62e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SLC22A1—obesity	3.51e-06	1.61e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CLOCK—obesity	3.51e-06	1.61e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GOT1—obesity	3.48e-06	1.6e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GGT1—obesity	3.48e-06	1.6e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NCOA1—obesity	3.46e-06	1.59e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GOT2—obesity	3.44e-06	1.59e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NCOA1—obesity	3.43e-06	1.58e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SULT2A1—obesity	3.42e-06	1.57e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GLP1R—obesity	3.42e-06	1.57e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—STK11—obesity	3.41e-06	1.57e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP19A1—obesity	3.41e-06	1.57e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MTHFR—obesity	3.4e-06	1.57e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.4e-06	1.56e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP19A1—obesity	3.38e-06	1.55e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—STK11—obesity	3.38e-06	1.55e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PIK3CD—obesity	3.37e-06	1.55e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—FASN—obesity	3.37e-06	1.55e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—DPYD—obesity	3.36e-06	1.55e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—COMT—obesity	3.36e-06	1.55e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—BCHE—obesity	3.36e-06	1.55e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PPARA—obesity	3.34e-06	1.54e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ALB—obesity	3.33e-06	1.53e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GNB3—obesity	3.31e-06	1.53e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPARGC1A—obesity	3.31e-06	1.53e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—HMOX1—obesity	3.3e-06	1.52e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP2E1—obesity	3.24e-06	1.49e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PRKAR2B—obesity	3.24e-06	1.49e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AGT—obesity	3.23e-06	1.49e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GNAS—obesity	3.23e-06	1.49e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—DCN—obesity	3.21e-06	1.48e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NQO1—obesity	3.2e-06	1.47e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—NOS3—obesity	3.18e-06	1.47e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PIK3R1—obesity	3.18e-06	1.47e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—COMT—obesity	3.17e-06	1.46e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—APOE—obesity	3.17e-06	1.46e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—APOB—obesity	3.16e-06	1.45e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—COMT—obesity	3.14e-06	1.45e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CAV1—obesity	3.14e-06	1.44e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	3.13e-06	1.44e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—APOA1—obesity	3.13e-06	1.44e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CPT1A—obesity	3.13e-06	1.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GNB3—obesity	3.12e-06	1.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPARGC1A—obesity	3.12e-06	1.44e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—HMOX1—obesity	3.11e-06	1.43e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	3.11e-06	1.43e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GNB3—obesity	3.1e-06	1.43e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPARGC1A—obesity	3.1e-06	1.43e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—HMOX1—obesity	3.08e-06	1.42e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GCG—obesity	3.07e-06	1.41e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SLC2A4—obesity	3.07e-06	1.41e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NAMPT—obesity	3.06e-06	1.41e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—LIPC—obesity	3.05e-06	1.4e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GCK—obesity	3.05e-06	1.4e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GNAS—obesity	3.04e-06	1.4e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYCS—obesity	3.03e-06	1.39e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOC3—obesity	3.03e-06	1.39e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—LPL—obesity	3.02e-06	1.39e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GNAS—obesity	3.01e-06	1.39e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3e-06	1.38e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—APOB—obesity	2.98e-06	1.37e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GOT1—obesity	2.97e-06	1.37e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GGT1—obesity	2.97e-06	1.37e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—APOB—obesity	2.95e-06	1.36e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GPX1—obesity	2.94e-06	1.36e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PIK3CB—obesity	2.94e-06	1.35e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CETP—obesity	2.94e-06	1.35e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NCOA1—obesity	2.93e-06	1.35e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS2—obesity	2.91e-06	1.34e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SDC1—obesity	2.91e-06	1.34e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—STK11—obesity	2.89e-06	1.33e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP19A1—obesity	2.89e-06	1.33e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CD36—obesity	2.87e-06	1.32e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PIK3CA—obesity	2.86e-06	1.32e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AKR1C3—obesity	2.86e-06	1.32e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3CG—obesity	2.86e-06	1.32e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—LPL—obesity	2.84e-06	1.31e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—LPL—obesity	2.82e-06	1.3e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SCARB1—obesity	2.81e-06	1.3e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GPX1—obesity	2.77e-06	1.28e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PPARG—obesity	2.76e-06	1.27e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GPX1—obesity	2.75e-06	1.27e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SREBF1—obesity	2.73e-06	1.26e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—POMC—obesity	2.72e-06	1.25e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MTHFR—obesity	2.72e-06	1.25e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—INS—obesity	2.7e-06	1.25e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CD36—obesity	2.7e-06	1.24e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—COMT—obesity	2.68e-06	1.24e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CD36—obesity	2.68e-06	1.23e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPARA—obesity	2.66e-06	1.23e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GOT2—obesity	2.66e-06	1.22e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GNB3—obesity	2.65e-06	1.22e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPARGC1A—obesity	2.65e-06	1.22e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—HMOX1—obesity	2.63e-06	1.21e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—FASN—obesity	2.6e-06	1.2e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—BCHE—obesity	2.59e-06	1.19e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AGT—obesity	2.58e-06	1.19e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GNAS—obesity	2.58e-06	1.19e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MTHFR—obesity	2.56e-06	1.18e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MTHFR—obesity	2.54e-06	1.17e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—APOE—obesity	2.53e-06	1.16e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—APOB—obesity	2.52e-06	1.16e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3CD—obesity	2.51e-06	1.16e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPARA—obesity	2.51e-06	1.16e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CAV1—obesity	2.51e-06	1.15e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—APOA1—obesity	2.5e-06	1.15e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP2E1—obesity	2.5e-06	1.15e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPARA—obesity	2.49e-06	1.15e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ALB—obesity	2.48e-06	1.14e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NQO1—obesity	2.47e-06	1.14e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AGT—obesity	2.43e-06	1.12e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AGT—obesity	2.41e-06	1.11e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—LPL—obesity	2.41e-06	1.11e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—APOE—obesity	2.38e-06	1.1e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3R1—obesity	2.37e-06	1.09e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NOS3—obesity	2.37e-06	1.09e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GCG—obesity	2.37e-06	1.09e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SLC2A4—obesity	2.37e-06	1.09e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—APOE—obesity	2.36e-06	1.09e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CAV1—obesity	2.36e-06	1.09e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—APOA1—obesity	2.36e-06	1.08e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GPX1—obesity	2.35e-06	1.08e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CAV1—obesity	2.34e-06	1.08e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYCS—obesity	2.34e-06	1.08e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—AKT1—obesity	2.34e-06	1.08e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—APOA1—obesity	2.34e-06	1.08e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PIK3CA—obesity	2.32e-06	1.07e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GGT1—obesity	2.29e-06	1.06e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GOT1—obesity	2.29e-06	1.06e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CD36—obesity	2.29e-06	1.05e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3CG—obesity	2.28e-06	1.05e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NCOA1—obesity	2.26e-06	1.04e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.24e-06	1.03e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—STK11—obesity	2.23e-06	1.03e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP19A1—obesity	2.23e-06	1.03e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPARG—obesity	2.2e-06	1.01e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3CB—obesity	2.19e-06	1.01e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—POMC—obesity	2.17e-06	1e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS2—obesity	2.17e-06	9.99e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MTHFR—obesity	2.17e-06	9.99e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—INS—obesity	2.16e-06	9.95e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3CG—obesity	2.15e-06	9.9e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3CG—obesity	2.13e-06	9.82e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPARA—obesity	2.13e-06	9.8e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPARG—obesity	2.08e-06	9.56e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—COMT—obesity	2.07e-06	9.53e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AGT—obesity	2.06e-06	9.49e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPARG—obesity	2.06e-06	9.48e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—POMC—obesity	2.05e-06	9.43e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPARGC1A—obesity	2.04e-06	9.4e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GNB3—obesity	2.04e-06	9.4e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—INS—obesity	2.04e-06	9.37e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HMOX1—obesity	2.03e-06	9.36e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—POMC—obesity	2.03e-06	9.35e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—APOE—obesity	2.02e-06	9.3e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—INS—obesity	2.02e-06	9.29e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3CD—obesity	2.01e-06	9.24e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CAV1—obesity	2e-06	9.21e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—APOA1—obesity	2e-06	9.19e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GNAS—obesity	1.99e-06	9.15e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ALB—obesity	1.98e-06	9.12e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOB—obesity	1.95e-06	8.96e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.91e-06	8.8e-06	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—AKT1—obesity	1.9e-06	8.74e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3R1—obesity	1.89e-06	8.72e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NOS3—obesity	1.89e-06	8.72e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3CD—obesity	1.89e-06	8.71e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3CD—obesity	1.87e-06	8.63e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ALB—obesity	1.87e-06	8.59e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—LPL—obesity	1.86e-06	8.56e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ALB—obesity	1.85e-06	8.52e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3CG—obesity	1.82e-06	8.39e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GPX1—obesity	1.81e-06	8.35e-06	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PIK3CA—obesity	1.79e-06	8.25e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NOS3—obesity	1.79e-06	8.22e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3R1—obesity	1.79e-06	8.22e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NOS3—obesity	1.77e-06	8.15e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3R1—obesity	1.77e-06	8.15e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CD36—obesity	1.77e-06	8.13e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPARG—obesity	1.76e-06	8.1e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3CB—obesity	1.75e-06	8.05e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—POMC—obesity	1.73e-06	7.99e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS2—obesity	1.73e-06	7.98e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—INS—obesity	1.72e-06	7.94e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MTHFR—obesity	1.67e-06	7.71e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3CB—obesity	1.65e-06	7.59e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPARA—obesity	1.64e-06	7.56e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3CB—obesity	1.63e-06	7.52e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS2—obesity	1.63e-06	7.52e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS2—obesity	1.62e-06	7.45e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3CD—obesity	1.6e-06	7.38e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AGT—obesity	1.59e-06	7.32e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALB—obesity	1.58e-06	7.28e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOE—obesity	1.56e-06	7.17e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CAV1—obesity	1.54e-06	7.11e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APOA1—obesity	1.54e-06	7.09e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3R1—obesity	1.51e-06	6.96e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NOS3—obesity	1.51e-06	6.96e-06	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—AKT1—obesity	1.46e-06	6.74e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3CG—obesity	1.41e-06	6.47e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3CB—obesity	1.4e-06	6.43e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS2—obesity	1.38e-06	6.37e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPARG—obesity	1.36e-06	6.25e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—POMC—obesity	1.34e-06	6.16e-06	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3CA—obesity	1.33e-06	6.15e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—INS—obesity	1.33e-06	6.13e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3CD—obesity	1.24e-06	5.69e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALB—obesity	1.22e-06	5.62e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3R1—obesity	1.17e-06	5.37e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NOS3—obesity	1.17e-06	5.37e-06	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AKT1—obesity	1.09e-06	5.02e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3CB—obesity	1.08e-06	4.96e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS2—obesity	1.07e-06	4.92e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3CA—obesity	1.07e-06	4.91e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3CA—obesity	1e-06	4.63e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3CA—obesity	9.96e-07	4.59e-06	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AKT1—obesity	8.71e-07	4.01e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3CA—obesity	8.51e-07	3.92e-06	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AKT1—obesity	8.21e-07	3.78e-06	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AKT1—obesity	8.14e-07	3.75e-06	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AKT1—obesity	6.95e-07	3.2e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3CA—obesity	6.57e-07	3.02e-06	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AKT1—obesity	5.37e-07	2.47e-06	CbGpPWpGaD
